Ocugen (OCGN) Net Income Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 60.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 19.97% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -1.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.86% |
| Dec 31, 2025 | 6.03% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | 11.70% |
| Mar 31, 2025 | 6.70% |
| Dec 31, 2024 | 1.27% |
| Sep 30, 2024 | -6.44% |
| Jun 30, 2024 | 15.83% |
| Mar 31, 2024 | -18.96% |
| Dec 31, 2023 | -45.16% |
| Sep 30, 2023 | -5.88% |
| Jun 30, 2023 | -86.76% |
| Mar 31, 2023 | -65.98% |
| Dec 31, 2022 | -72.23% |
| Sep 30, 2022 | -84.16% |
| Jun 30, 2022 | -102.72% |
| Mar 31, 2022 | -50.92% |
| Dec 31, 2021 | -31.56% |
| Sep 30, 2021 | -46.76% |
| Jun 30, 2021 | -52.30% |
| Mar 31, 2021 | -5.33% |
| Dec 31, 2020 | 14.43% |
| Sep 30, 2020 | -22.67% |
| Jun 30, 2020 | 17.06% |
| Mar 31, 2020 | 16.58% |
| Dec 31, 2019 | 18.44% |
| Sep 30, 2019 | 19.34% |
| Jun 30, 2019 | 31.31% |
| Mar 31, 2019 | 10.94% |
| Dec 31, 2018 | 8.42% |
| Sep 30, 2018 | 24.99% |
| Jun 30, 2018 | 1.63% |
| Mar 31, 2018 | 8.61% |
| Dec 31, 2017 | 3.40% |
| Sep 30, 2017 | 27.61% |
| Jun 30, 2017 | -1.77% |
| Mar 31, 2017 | -9.52% |